ANI Pharmaceuticals | ANIP - Umsatzerlöse





Der Umsatz Veränderung Datum
AbbVie USD 16.99B 1.99B 2026-06
ANI Pharmaceuticals USD 266M 28.5M 2026-06
Aurora Cannabis CAD 38.01M 56.18M 2026-03
Canopy Growth CAD 71.25M 3.29M 2026-03
Eli Lilly USD 22.97B 3.17B 2026-06
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Novartis USD 13.11B 750M 2026-03
Perrigo USD 1.02B 51M 2026-06
Sun Pharmaceuticals INR 153B 7.14B 2026-06
Teva Pharmaceutical Industries USD 12.67B 900M 2026-06